Gene Therapy Drug Approval Granted to GSK

May 31, 2016

(BBC) – Regulators have given one of the world’s largest drug companies approval to sell a new gene therapy. The treatment is for an illness called ADA-SCID which prevents babies from fighting off everyday infections. This is the first approval for a genetic therapy granted to a large multinational drug company, GSK. Commentators say the development marks the beginning of many more genetic medicines from so-called “Big Pharma”.

Posted by

Posted in Genetic Ethics, News, Pharma